T
he ␤ 2 -adrenoceptor (␤ 2 -ADR) mediates vasodilatation and lipolysis in response to epinephrine. 1 A C79G (Gln27Glu) variant of ADRB2R has shown association with overweight or obesity, [2] [3] [4] [5] [6] elevation in systolic blood pressure (BP), 7, 8 and hypertension (HT). 7, 9 Suggestive linkage with HT exists near ADRB2R 8, 10 (5q32-q34) and Glu27 is associated with lower baseline blood flow, attenuated increase in forearm blood flow in response to isoproterenol, 11 and ␤ 2 -ADR downregulation. 12 However, other investigators find no association [13] [14] [15] or linkage 16 with overweight or obesity, nor an association 16 or linkage 17, 18 with BP, nor an association with HT. 16, 19, 20 Here we address this controversy in a cohort of white Australian patients of Anglo-Celtic origin with strong genetic predisposition to HT (two HT parents).
Methods

Subjects
Ascertainment and characteristics were as described previously.
21-24
Genotyping
The genotyping was done by polymerase chain reactionrestriction fragment length polymorphism using 30 ng of genomic DNA, primers: 5Ј-atggggcaacccgggaacggc-3Ј and 5Ј-agtccacattttcataagaat-3Ј, 0.1 U AmpliTaqTM (Perkin-Elmer, Applied Biosystems, Norwalk, CT), followed by 1 U TseI (New England BioLabs, Beverly, MA) at 65°C for 1 h.
Statistical Analyses
2 and ANOVA used StatView (Abacus Concepts, Berkeley, CA). Relative risk, odds ratio, 25 power, 26 and Bonferroni correction 27 were calculated as described.
Results
Hardy Weinberg equilibrium was observed. Glu27 frequency was similar in each group (Table 1) and did not differ between sexes. Power to detect association with HT was 72%. In overweight HT (body mass index [BMI] Ն25 kg/m 2 ) Glu27 frequency was elevated (Table 1) , power being 86%, and was similar in each sex. Odds ratio for Gln/Gln versus Glu/Glu in HT was 1.6 (95% confidence interval [CI] 0.57-4.71), and for Glu/Glu versus Gln/Glu was 2.3 (95% CI 1.02-5.07). Glu27 also tracked with elevation of BMI in HT (Fig. 1) . Relative risk of being overweight with Glu27 was 1.4 (95% CI 0.84 -1.71). The NT group showed no association with overweight, BMI, plasma lipids, BP, or any other parameter after Bonferonni correction.
Discussion
Like other researchers, 16, 19, 20 we saw no association of the Gln27Glu variant with HT. Our data support, however, findings of a contribution to overweight or obesity. [2] [3] [4] [5] [6] Discrepancies in the literature could be contributed by ethnicity. For example, the Glu27 variant confers attenuated vasodilatation in response to epinephrine agonists in African, but not in white, Americans, 28 and could contribute to elevated mortality from HT cardiovascular disease in the former. 20, 29 Furthermore, the Glu27 allele is protective against vascular hyperreactivity, 11 and correlates with lower mortality in advanced heart failure. 30 This could explain the higher prevalence of Glu27 in whites as opposed to African Americans. 20, 29 Although our data do not support a role for the Gln27Glu variant in HT, they do not exclude a role for other variants in or near ADRB2R, nor involvement of Gln27Glu in other populations. 8 -10,31,32 The association of Glu27 with overweight in HT is seen in different ethnic groups. 33 Glu/Glu was associated with obesity in Swedish women, 2 and obesity and fat distribution in Japanese 4,5 ; German 13 and Austrian 14 reports were, however, negative, as were studies of Swedish 34 and Danish men. 35 In a French study, Gln/Gln was associated with obesity in men. 6 Gender-specific variations could explain discrepancies, given higher Glu27 frequency in obese Swedish women, 2,3 whose genetic background should be similar to Danes. 35 A sex-specific effect could also explain lack of association in Japanese men. 15 Because association with overweight was confined to our HT group, HT might have to exist for an association to become apparent, and could explain disparities between studies.
␤-ADR subtypes differ in effect on fat accumulation and lipolysis.
36 -39 ␤ 2 -ADR, like ␤ 1 -ADR, is expressed primarily in subcutaneous fat, whereas ␤ 3 -ADR is the major ␤-adrenoceptor in visceral adipose tissue. Because women tend to accumulate fat subcutaneously, 2,3 whereas men do so viscerally, 5 an alteration of the ␤ 2 -ADR might be likely to affect lipolysis in subcutaneous adipose tissue of women more than men. In our study the Gln27 variant was associated with overweight in HT of both sexes. However, we did not determine fat distribution in our subjects, so we cannot comment on genotypic effect in different adipose regions.
In conclusion, the ␤ 2 -ADR Gln27Glu polymorphism is not a risk factor for HT in our population, but is associated with overweight and increased BMI.
